Global Antiandrogen Drugs Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Antiandrogen Drugs market size was valued at US$ 8468 million in 2025 and is forecast to a readjusted size of US$ 11676 million by 2032 with a CAGR of 4.7% during review period.
Antiandrogen Drugs are pharmacological agents that directly block or inhibit androgen receptor activity and thereby reduce the biological effects of testosterone, dihydrotestosterone and related androgens in androgen-responsive tissues. This study focuses on direct androgen receptor antagonists used primarily in prostate cancer, covering first-generation agents such as bicalutamide, flutamide and nilutamide and next-generation androgen receptor inhibitors such as enzalutamide, apalutamide and darolutamide. The market is predominantly composed of small-molecule oral solid dosage forms, including tablets, film-coated tablets, capsules and soft capsules, with product specifications differentiated by active ingredient, strength, formulation, dosing schedule and approved disease setting. The therapeutic mechanism centers on preventing androgen-driven receptor signaling and, for newer agents, more comprehensive inhibition of androgen receptor activation, nuclear translocation and downstream transcriptional activity. Antiandrogen Drugs are used across castration-sensitive and castration-resistant prostate cancer settings, often together with medical or surgical androgen-deprivation strategies depending on the specific approved indication.
Global Antiandrogen Drugs market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antiandrogen Drugs market size and forecasts, by Structure and by Application, in consumption value ($ Million), 2021-2032
Global Antiandrogen Drugs market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Antiandrogen Drugs market is split by Structure and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Structure and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top players of Antiandrogen Drugs, with revenue, gross margin, and global market share of Antiandrogen Drugs from 2021 to 2026.
Chapter 3, the Antiandrogen Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Structure and by Application, with consumption value and growth rate by Structure, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Antiandrogen Drugs market forecast, by regions, by Structure and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiandrogen Drugs.
Chapter 13, to describe Antiandrogen Drugs research findings and conclusion.
Antiandrogen Drugs are pharmacological agents that directly block or inhibit androgen receptor activity and thereby reduce the biological effects of testosterone, dihydrotestosterone and related androgens in androgen-responsive tissues. This study focuses on direct androgen receptor antagonists used primarily in prostate cancer, covering first-generation agents such as bicalutamide, flutamide and nilutamide and next-generation androgen receptor inhibitors such as enzalutamide, apalutamide and darolutamide. The market is predominantly composed of small-molecule oral solid dosage forms, including tablets, film-coated tablets, capsules and soft capsules, with product specifications differentiated by active ingredient, strength, formulation, dosing schedule and approved disease setting. The therapeutic mechanism centers on preventing androgen-driven receptor signaling and, for newer agents, more comprehensive inhibition of androgen receptor activation, nuclear translocation and downstream transcriptional activity. Antiandrogen Drugs are used across castration-sensitive and castration-resistant prostate cancer settings, often together with medical or surgical androgen-deprivation strategies depending on the specific approved indication.
Report Scope
This report is a detailed and comprehensive analysis for global Antiandrogen Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Structure and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Antiandrogen Drugs market size and forecasts, in consumption value ($ Million), 2021-2032Global Antiandrogen Drugs market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Antiandrogen Drugs market size and forecasts, by Structure and by Application, in consumption value ($ Million), 2021-2032
Global Antiandrogen Drugs market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Antiandrogen Drugs
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Antiandrogen Drugs market is split by Structure and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Structure and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Structure
- Nonsteroidal Antiandrogens
- Steroidal Antiandrogens
Market segment by Shape
- Tablets
- Capsules
- Soft Capsules
Market segment by Application
- Non-Metastatic Castration-Resistant Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer
- Metastatic Castration-Sensitive Prostate Cancer
- High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
Market segment by players, this report covers
- Astellas Pharma Inc.
- Johnson & Johnson Innovative Medicine
- Bayer AG
- ANI Pharmaceuticals, Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Apotex Inc.
- Intas Pharmaceuticals Ltd.
- Cipla Ltd.
- Zydus Lifesciences Ltd.
- Sandoz Group AG
- Pinnacle Life Science Pvt. Ltd.
- Orion Corporation
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Shanghai Fudan Forward Pharmaceutical Co., Ltd.
- Shanghai Zhaohui Pharmaceutical Co., Ltd.
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Aurisco Pharmaceutical Co., Ltd.
- Qilu Pharmaceutical (Hainan) Co., Ltd.
- Chengdu Easton Biopharmaceuticals Co., Ltd.
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- Yangtze River Pharmaceutical Group Co., Ltd.
- Zhejiang Nuode Pharmaceutical Co., Ltd.
- Jiangxi Kerui Pharmaceutical Co., Ltd.
- Chengdu Better Pharmaceutical Co., Ltd.
- Shenyang Hongqi Pharmaceutical Co., Ltd.
- Yichang Humanwell Pharmaceutical Co., Ltd.
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Antiandrogen Drugs product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Antiandrogen Drugs, with revenue, gross margin, and global market share of Antiandrogen Drugs from 2021 to 2026.
Chapter 3, the Antiandrogen Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Structure and by Application, with consumption value and growth rate by Structure, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Antiandrogen Drugs market forecast, by regions, by Structure and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiandrogen Drugs.
Chapter 13, to describe Antiandrogen Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antiandrogen Drugs by Structure
1.3.1 Overview: Global Antiandrogen Drugs Market Size by Structure: 2021 Versus 2025 Versus 2032
1.3.2 Global Antiandrogen Drugs Consumption Value Market Share by Structure in 2025
1.3.3 Nonsteroidal Antiandrogens
1.3.4 Steroidal Antiandrogens
1.4 Classification of Antiandrogen Drugs by Shape
1.4.1 Overview: Global Antiandrogen Drugs Market Size by Shape: 2021 Versus 2025 Versus 2032
1.4.2 Global Antiandrogen Drugs Consumption Value Market Share by Shape in 2025
1.4.3 Tablets
1.4.4 Capsules
1.4.5 Soft Capsules
1.5 Global Antiandrogen Drugs Market by Application
1.5.1 Overview: Global Antiandrogen Drugs Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Non-Metastatic Castration-Resistant Prostate Cancer
1.5.3 Metastatic Castration-Resistant Prostate Cancer
1.5.4 Metastatic Castration-Sensitive Prostate Cancer
1.5.5 High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
1.6 Global Antiandrogen Drugs Market Size & Forecast
1.7 Global Antiandrogen Drugs Market Size and Forecast by Region
1.7.1 Global Antiandrogen Drugs Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Antiandrogen Drugs Market Size by Region, (2021-2032)
1.7.3 North America Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.4 Europe Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.6 South America Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Antiandrogen Drugs Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Antiandrogen Drugs Product and Solutions
2.1.4 Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.2 Johnson & Johnson Innovative Medicine
2.2.1 Johnson & Johnson Innovative Medicine Details
2.2.2 Johnson & Johnson Innovative Medicine Major Business
2.2.3 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Solutions
2.2.4 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Johnson & Johnson Innovative Medicine Recent Developments and Future Plans
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Antiandrogen Drugs Product and Solutions
2.3.4 Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bayer AG Recent Developments and Future Plans
2.4 ANI Pharmaceuticals, Inc.
2.4.1 ANI Pharmaceuticals, Inc. Details
2.4.2 ANI Pharmaceuticals, Inc. Major Business
2.4.3 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Solutions
2.4.4 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ANI Pharmaceuticals, Inc. Recent Developments and Future Plans
2.5 Sun Pharmaceutical Industries Ltd.
2.5.1 Sun Pharmaceutical Industries Ltd. Details
2.5.2 Sun Pharmaceutical Industries Ltd. Major Business
2.5.3 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
2.5.4 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
2.6.4 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.7 Apotex Inc.
2.7.1 Apotex Inc. Details
2.7.2 Apotex Inc. Major Business
2.7.3 Apotex Inc. Antiandrogen Drugs Product and Solutions
2.7.4 Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Apotex Inc. Recent Developments and Future Plans
2.8 Intas Pharmaceuticals Ltd.
2.8.1 Intas Pharmaceuticals Ltd. Details
2.8.2 Intas Pharmaceuticals Ltd. Major Business
2.8.3 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Solutions
2.8.4 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Intas Pharmaceuticals Ltd. Recent Developments and Future Plans
2.9 Cipla Ltd.
2.9.1 Cipla Ltd. Details
2.9.2 Cipla Ltd. Major Business
2.9.3 Cipla Ltd. Antiandrogen Drugs Product and Solutions
2.9.4 Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cipla Ltd. Recent Developments and Future Plans
2.10 Zydus Lifesciences Ltd.
2.10.1 Zydus Lifesciences Ltd. Details
2.10.2 Zydus Lifesciences Ltd. Major Business
2.10.3 Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Solutions
2.10.4 Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Zydus Lifesciences Ltd. Recent Developments and Future Plans
2.11 Sandoz Group AG
2.11.1 Sandoz Group AG Details
2.11.2 Sandoz Group AG Major Business
2.11.3 Sandoz Group AG Antiandrogen Drugs Product and Solutions
2.11.4 Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sandoz Group AG Recent Developments and Future Plans
2.12 Pinnacle Life Science Pvt. Ltd.
2.12.1 Pinnacle Life Science Pvt. Ltd. Details
2.12.2 Pinnacle Life Science Pvt. Ltd. Major Business
2.12.3 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Solutions
2.12.4 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Pinnacle Life Science Pvt. Ltd. Recent Developments and Future Plans
2.13 Orion Corporation
2.13.1 Orion Corporation Details
2.13.2 Orion Corporation Major Business
2.13.3 Orion Corporation Antiandrogen Drugs Product and Solutions
2.13.4 Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Orion Corporation Recent Developments and Future Plans
2.14 Zhejiang Hisun Pharmaceutical Co., Ltd.
2.14.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Details
2.14.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
2.14.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.14.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.15 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
2.15.1 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Details
2.15.2 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
2.15.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.15.4 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.16 Shanghai Zhaohui Pharmaceutical Co., Ltd.
2.16.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Details
2.16.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
2.16.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.16.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.17 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2.17.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Details
2.17.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
2.17.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
2.17.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.18 Aurisco Pharmaceutical Co., Ltd.
2.18.1 Aurisco Pharmaceutical Co., Ltd. Details
2.18.2 Aurisco Pharmaceutical Co., Ltd. Major Business
2.18.3 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.18.4 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Aurisco Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.19 Qilu Pharmaceutical (Hainan) Co., Ltd.
2.19.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
2.19.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
2.19.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Solutions
2.19.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments and Future Plans
2.20 Chengdu Easton Biopharmaceuticals Co., Ltd.
2.20.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Details
2.20.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
2.20.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Solutions
2.20.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments and Future Plans
2.21 Sichuan Kelun Pharmaceutical Co., Ltd.
2.21.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
2.21.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
2.21.3 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.21.4 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.22 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
2.22.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
2.22.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
2.22.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
2.22.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.23 Yangtze River Pharmaceutical Group Co., Ltd.
2.23.1 Yangtze River Pharmaceutical Group Co., Ltd. Details
2.23.2 Yangtze River Pharmaceutical Group Co., Ltd. Major Business
2.23.3 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
2.23.4 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.24 Zhejiang Nuode Pharmaceutical Co., Ltd.
2.24.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Details
2.24.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
2.24.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.24.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.25 Jiangxi Kerui Pharmaceutical Co., Ltd.
2.25.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Details
2.25.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
2.25.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.25.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.26 Chengdu Better Pharmaceutical Co., Ltd.
2.26.1 Chengdu Better Pharmaceutical Co., Ltd. Details
2.26.2 Chengdu Better Pharmaceutical Co., Ltd. Major Business
2.26.3 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.26.4 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Chengdu Better Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.27 Shenyang Hongqi Pharmaceutical Co., Ltd.
2.27.1 Shenyang Hongqi Pharmaceutical Co., Ltd. Details
2.27.2 Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
2.27.3 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.27.4 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.28 Yichang Humanwell Pharmaceutical Co., Ltd.
2.28.1 Yichang Humanwell Pharmaceutical Co., Ltd. Details
2.28.2 Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
2.28.3 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.28.4 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antiandrogen Drugs Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Antiandrogen Drugs by Company Revenue
3.2.2 Top 3 Antiandrogen Drugs Players Market Share in 2025
3.2.3 Top 6 Antiandrogen Drugs Players Market Share in 2025
3.3 Antiandrogen Drugs Market: Overall Company Footprint Analysis
3.3.1 Antiandrogen Drugs Market: Region Footprint
3.3.2 Antiandrogen Drugs Market: Company Product Type Footprint
3.3.3 Antiandrogen Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY STRUCTURE
4.1 Global Antiandrogen Drugs Consumption Value and Market Share by Structure (2021-2026)
4.2 Global Antiandrogen Drugs Market Forecast by Structure (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antiandrogen Drugs Consumption Value Market Share by Application (2021-2026)
5.2 Global Antiandrogen Drugs Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Antiandrogen Drugs Consumption Value by Structure (2021-2032)
6.2 North America Antiandrogen Drugs Market Size by Application (2021-2032)
6.3 North America Antiandrogen Drugs Market Size by Country
6.3.1 North America Antiandrogen Drugs Consumption Value by Country (2021-2032)
6.3.2 United States Antiandrogen Drugs Market Size and Forecast (2021-2032)
6.3.3 Canada Antiandrogen Drugs Market Size and Forecast (2021-2032)
6.3.4 Mexico Antiandrogen Drugs Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Antiandrogen Drugs Consumption Value by Structure (2021-2032)
7.2 Europe Antiandrogen Drugs Consumption Value by Application (2021-2032)
7.3 Europe Antiandrogen Drugs Market Size by Country
7.3.1 Europe Antiandrogen Drugs Consumption Value by Country (2021-2032)
7.3.2 Germany Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.3 France Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.5 Russia Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.6 Italy Antiandrogen Drugs Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antiandrogen Drugs Consumption Value by Structure (2021-2032)
8.2 Asia-Pacific Antiandrogen Drugs Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Antiandrogen Drugs Market Size by Region
8.3.1 Asia-Pacific Antiandrogen Drugs Consumption Value by Region (2021-2032)
8.3.2 China Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.3 Japan Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.4 South Korea Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.5 India Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.7 Australia Antiandrogen Drugs Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Antiandrogen Drugs Consumption Value by Structure (2021-2032)
9.2 South America Antiandrogen Drugs Consumption Value by Application (2021-2032)
9.3 South America Antiandrogen Drugs Market Size by Country
9.3.1 South America Antiandrogen Drugs Consumption Value by Country (2021-2032)
9.3.2 Brazil Antiandrogen Drugs Market Size and Forecast (2021-2032)
9.3.3 Argentina Antiandrogen Drugs Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antiandrogen Drugs Consumption Value by Structure (2021-2032)
10.2 Middle East & Africa Antiandrogen Drugs Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Antiandrogen Drugs Market Size by Country
10.3.1 Middle East & Africa Antiandrogen Drugs Consumption Value by Country (2021-2032)
10.3.2 Turkey Antiandrogen Drugs Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Antiandrogen Drugs Market Size and Forecast (2021-2032)
10.3.4 UAE Antiandrogen Drugs Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Antiandrogen Drugs Market Drivers
11.2 Antiandrogen Drugs Market Restraints
11.3 Antiandrogen Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antiandrogen Drugs Industry Chain
12.2 Antiandrogen Drugs Upstream Analysis
12.3 Antiandrogen Drugs Midstream Analysis
12.4 Antiandrogen Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antiandrogen Drugs by Structure
1.3.1 Overview: Global Antiandrogen Drugs Market Size by Structure: 2021 Versus 2025 Versus 2032
1.3.2 Global Antiandrogen Drugs Consumption Value Market Share by Structure in 2025
1.3.3 Nonsteroidal Antiandrogens
1.3.4 Steroidal Antiandrogens
1.4 Classification of Antiandrogen Drugs by Shape
1.4.1 Overview: Global Antiandrogen Drugs Market Size by Shape: 2021 Versus 2025 Versus 2032
1.4.2 Global Antiandrogen Drugs Consumption Value Market Share by Shape in 2025
1.4.3 Tablets
1.4.4 Capsules
1.4.5 Soft Capsules
1.5 Global Antiandrogen Drugs Market by Application
1.5.1 Overview: Global Antiandrogen Drugs Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Non-Metastatic Castration-Resistant Prostate Cancer
1.5.3 Metastatic Castration-Resistant Prostate Cancer
1.5.4 Metastatic Castration-Sensitive Prostate Cancer
1.5.5 High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer
1.6 Global Antiandrogen Drugs Market Size & Forecast
1.7 Global Antiandrogen Drugs Market Size and Forecast by Region
1.7.1 Global Antiandrogen Drugs Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Antiandrogen Drugs Market Size by Region, (2021-2032)
1.7.3 North America Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.4 Europe Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.6 South America Antiandrogen Drugs Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Antiandrogen Drugs Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Antiandrogen Drugs Product and Solutions
2.1.4 Astellas Pharma Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Astellas Pharma Inc. Recent Developments and Future Plans
2.2 Johnson & Johnson Innovative Medicine
2.2.1 Johnson & Johnson Innovative Medicine Details
2.2.2 Johnson & Johnson Innovative Medicine Major Business
2.2.3 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Solutions
2.2.4 Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Johnson & Johnson Innovative Medicine Recent Developments and Future Plans
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Antiandrogen Drugs Product and Solutions
2.3.4 Bayer AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Bayer AG Recent Developments and Future Plans
2.4 ANI Pharmaceuticals, Inc.
2.4.1 ANI Pharmaceuticals, Inc. Details
2.4.2 ANI Pharmaceuticals, Inc. Major Business
2.4.3 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Solutions
2.4.4 ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ANI Pharmaceuticals, Inc. Recent Developments and Future Plans
2.5 Sun Pharmaceutical Industries Ltd.
2.5.1 Sun Pharmaceutical Industries Ltd. Details
2.5.2 Sun Pharmaceutical Industries Ltd. Major Business
2.5.3 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
2.5.4 Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Teva Pharmaceutical Industries Ltd. Details
2.6.2 Teva Pharmaceutical Industries Ltd. Major Business
2.6.3 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
2.6.4 Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.7 Apotex Inc.
2.7.1 Apotex Inc. Details
2.7.2 Apotex Inc. Major Business
2.7.3 Apotex Inc. Antiandrogen Drugs Product and Solutions
2.7.4 Apotex Inc. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Apotex Inc. Recent Developments and Future Plans
2.8 Intas Pharmaceuticals Ltd.
2.8.1 Intas Pharmaceuticals Ltd. Details
2.8.2 Intas Pharmaceuticals Ltd. Major Business
2.8.3 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Solutions
2.8.4 Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Intas Pharmaceuticals Ltd. Recent Developments and Future Plans
2.9 Cipla Ltd.
2.9.1 Cipla Ltd. Details
2.9.2 Cipla Ltd. Major Business
2.9.3 Cipla Ltd. Antiandrogen Drugs Product and Solutions
2.9.4 Cipla Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cipla Ltd. Recent Developments and Future Plans
2.10 Zydus Lifesciences Ltd.
2.10.1 Zydus Lifesciences Ltd. Details
2.10.2 Zydus Lifesciences Ltd. Major Business
2.10.3 Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Solutions
2.10.4 Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Zydus Lifesciences Ltd. Recent Developments and Future Plans
2.11 Sandoz Group AG
2.11.1 Sandoz Group AG Details
2.11.2 Sandoz Group AG Major Business
2.11.3 Sandoz Group AG Antiandrogen Drugs Product and Solutions
2.11.4 Sandoz Group AG Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Sandoz Group AG Recent Developments and Future Plans
2.12 Pinnacle Life Science Pvt. Ltd.
2.12.1 Pinnacle Life Science Pvt. Ltd. Details
2.12.2 Pinnacle Life Science Pvt. Ltd. Major Business
2.12.3 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Solutions
2.12.4 Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Pinnacle Life Science Pvt. Ltd. Recent Developments and Future Plans
2.13 Orion Corporation
2.13.1 Orion Corporation Details
2.13.2 Orion Corporation Major Business
2.13.3 Orion Corporation Antiandrogen Drugs Product and Solutions
2.13.4 Orion Corporation Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Orion Corporation Recent Developments and Future Plans
2.14 Zhejiang Hisun Pharmaceutical Co., Ltd.
2.14.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Details
2.14.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
2.14.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.14.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.15 Shanghai Fudan Forward Pharmaceutical Co., Ltd.
2.15.1 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Details
2.15.2 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
2.15.3 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.15.4 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.16 Shanghai Zhaohui Pharmaceutical Co., Ltd.
2.16.1 Shanghai Zhaohui Pharmaceutical Co., Ltd. Details
2.16.2 Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
2.16.3 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.16.4 Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.17 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
2.17.1 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Details
2.17.2 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
2.17.3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
2.17.4 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.18 Aurisco Pharmaceutical Co., Ltd.
2.18.1 Aurisco Pharmaceutical Co., Ltd. Details
2.18.2 Aurisco Pharmaceutical Co., Ltd. Major Business
2.18.3 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.18.4 Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Aurisco Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.19 Qilu Pharmaceutical (Hainan) Co., Ltd.
2.19.1 Qilu Pharmaceutical (Hainan) Co., Ltd. Details
2.19.2 Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
2.19.3 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Solutions
2.19.4 Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments and Future Plans
2.20 Chengdu Easton Biopharmaceuticals Co., Ltd.
2.20.1 Chengdu Easton Biopharmaceuticals Co., Ltd. Details
2.20.2 Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
2.20.3 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Solutions
2.20.4 Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments and Future Plans
2.21 Sichuan Kelun Pharmaceutical Co., Ltd.
2.21.1 Sichuan Kelun Pharmaceutical Co., Ltd. Details
2.21.2 Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
2.21.3 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.21.4 Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.22 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
2.22.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
2.22.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
2.22.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
2.22.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.23 Yangtze River Pharmaceutical Group Co., Ltd.
2.23.1 Yangtze River Pharmaceutical Group Co., Ltd. Details
2.23.2 Yangtze River Pharmaceutical Group Co., Ltd. Major Business
2.23.3 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
2.23.4 Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
2.24 Zhejiang Nuode Pharmaceutical Co., Ltd.
2.24.1 Zhejiang Nuode Pharmaceutical Co., Ltd. Details
2.24.2 Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
2.24.3 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.24.4 Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.25 Jiangxi Kerui Pharmaceutical Co., Ltd.
2.25.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Details
2.25.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
2.25.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.25.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.26 Chengdu Better Pharmaceutical Co., Ltd.
2.26.1 Chengdu Better Pharmaceutical Co., Ltd. Details
2.26.2 Chengdu Better Pharmaceutical Co., Ltd. Major Business
2.26.3 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.26.4 Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Chengdu Better Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.27 Shenyang Hongqi Pharmaceutical Co., Ltd.
2.27.1 Shenyang Hongqi Pharmaceutical Co., Ltd. Details
2.27.2 Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
2.27.3 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.27.4 Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.27.5 Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments and Future Plans
2.28 Yichang Humanwell Pharmaceutical Co., Ltd.
2.28.1 Yichang Humanwell Pharmaceutical Co., Ltd. Details
2.28.2 Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
2.28.3 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
2.28.4 Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue, Gross Margin and Market Share (2021-2026)
2.28.5 Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antiandrogen Drugs Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Antiandrogen Drugs by Company Revenue
3.2.2 Top 3 Antiandrogen Drugs Players Market Share in 2025
3.2.3 Top 6 Antiandrogen Drugs Players Market Share in 2025
3.3 Antiandrogen Drugs Market: Overall Company Footprint Analysis
3.3.1 Antiandrogen Drugs Market: Region Footprint
3.3.2 Antiandrogen Drugs Market: Company Product Type Footprint
3.3.3 Antiandrogen Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY STRUCTURE
4.1 Global Antiandrogen Drugs Consumption Value and Market Share by Structure (2021-2026)
4.2 Global Antiandrogen Drugs Market Forecast by Structure (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antiandrogen Drugs Consumption Value Market Share by Application (2021-2026)
5.2 Global Antiandrogen Drugs Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Antiandrogen Drugs Consumption Value by Structure (2021-2032)
6.2 North America Antiandrogen Drugs Market Size by Application (2021-2032)
6.3 North America Antiandrogen Drugs Market Size by Country
6.3.1 North America Antiandrogen Drugs Consumption Value by Country (2021-2032)
6.3.2 United States Antiandrogen Drugs Market Size and Forecast (2021-2032)
6.3.3 Canada Antiandrogen Drugs Market Size and Forecast (2021-2032)
6.3.4 Mexico Antiandrogen Drugs Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Antiandrogen Drugs Consumption Value by Structure (2021-2032)
7.2 Europe Antiandrogen Drugs Consumption Value by Application (2021-2032)
7.3 Europe Antiandrogen Drugs Market Size by Country
7.3.1 Europe Antiandrogen Drugs Consumption Value by Country (2021-2032)
7.3.2 Germany Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.3 France Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.5 Russia Antiandrogen Drugs Market Size and Forecast (2021-2032)
7.3.6 Italy Antiandrogen Drugs Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antiandrogen Drugs Consumption Value by Structure (2021-2032)
8.2 Asia-Pacific Antiandrogen Drugs Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Antiandrogen Drugs Market Size by Region
8.3.1 Asia-Pacific Antiandrogen Drugs Consumption Value by Region (2021-2032)
8.3.2 China Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.3 Japan Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.4 South Korea Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.5 India Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Antiandrogen Drugs Market Size and Forecast (2021-2032)
8.3.7 Australia Antiandrogen Drugs Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Antiandrogen Drugs Consumption Value by Structure (2021-2032)
9.2 South America Antiandrogen Drugs Consumption Value by Application (2021-2032)
9.3 South America Antiandrogen Drugs Market Size by Country
9.3.1 South America Antiandrogen Drugs Consumption Value by Country (2021-2032)
9.3.2 Brazil Antiandrogen Drugs Market Size and Forecast (2021-2032)
9.3.3 Argentina Antiandrogen Drugs Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antiandrogen Drugs Consumption Value by Structure (2021-2032)
10.2 Middle East & Africa Antiandrogen Drugs Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Antiandrogen Drugs Market Size by Country
10.3.1 Middle East & Africa Antiandrogen Drugs Consumption Value by Country (2021-2032)
10.3.2 Turkey Antiandrogen Drugs Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Antiandrogen Drugs Market Size and Forecast (2021-2032)
10.3.4 UAE Antiandrogen Drugs Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Antiandrogen Drugs Market Drivers
11.2 Antiandrogen Drugs Market Restraints
11.3 Antiandrogen Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antiandrogen Drugs Industry Chain
12.2 Antiandrogen Drugs Upstream Analysis
12.3 Antiandrogen Drugs Midstream Analysis
12.4 Antiandrogen Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antiandrogen Drugs Consumption Value by Structure, (USD Million), 2021 & 2025 & 2032
Table 2. Global Antiandrogen Drugs Consumption Value by Shape, (USD Million), 2021 & 2025 & 2032
Table 3. Global Antiandrogen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Antiandrogen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Antiandrogen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Inc. Major Business
Table 8. Astellas Pharma Inc. Antiandrogen Drugs Product and Solutions
Table 9. Astellas Pharma Inc. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Astellas Pharma Inc. Recent Developments and Future Plans
Table 11. Johnson & Johnson Innovative Medicine Company Information, Head Office, and Major Competitors
Table 12. Johnson & Johnson Innovative Medicine Major Business
Table 13. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Solutions
Table 14. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Johnson & Johnson Innovative Medicine Recent Developments and Future Plans
Table 16. Bayer AG Company Information, Head Office, and Major Competitors
Table 17. Bayer AG Major Business
Table 18. Bayer AG Antiandrogen Drugs Product and Solutions
Table 19. Bayer AG Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. ANI Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 21. ANI Pharmaceuticals, Inc. Major Business
Table 22. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Solutions
Table 23. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. ANI Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 25. Sun Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 26. Sun Pharmaceutical Industries Ltd. Major Business
Table 27. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
Table 28. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sun Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Ltd. Major Business
Table 32. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
Table 33. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 35. Apotex Inc. Company Information, Head Office, and Major Competitors
Table 36. Apotex Inc. Major Business
Table 37. Apotex Inc. Antiandrogen Drugs Product and Solutions
Table 38. Apotex Inc. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Apotex Inc. Recent Developments and Future Plans
Table 40. Intas Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 41. Intas Pharmaceuticals Ltd. Major Business
Table 42. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Solutions
Table 43. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Intas Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 45. Cipla Ltd. Company Information, Head Office, and Major Competitors
Table 46. Cipla Ltd. Major Business
Table 47. Cipla Ltd. Antiandrogen Drugs Product and Solutions
Table 48. Cipla Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Cipla Ltd. Recent Developments and Future Plans
Table 50. Zydus Lifesciences Ltd. Company Information, Head Office, and Major Competitors
Table 51. Zydus Lifesciences Ltd. Major Business
Table 52. Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Solutions
Table 53. Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Zydus Lifesciences Ltd. Recent Developments and Future Plans
Table 55. Sandoz Group AG Company Information, Head Office, and Major Competitors
Table 56. Sandoz Group AG Major Business
Table 57. Sandoz Group AG Antiandrogen Drugs Product and Solutions
Table 58. Sandoz Group AG Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Sandoz Group AG Recent Developments and Future Plans
Table 60. Pinnacle Life Science Pvt. Ltd. Company Information, Head Office, and Major Competitors
Table 61. Pinnacle Life Science Pvt. Ltd. Major Business
Table 62. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Solutions
Table 63. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Pinnacle Life Science Pvt. Ltd. Recent Developments and Future Plans
Table 65. Orion Corporation Company Information, Head Office, and Major Competitors
Table 66. Orion Corporation Major Business
Table 67. Orion Corporation Antiandrogen Drugs Product and Solutions
Table 68. Orion Corporation Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Orion Corporation Recent Developments and Future Plans
Table 70. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 71. Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
Table 72. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 73. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 75. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 76. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
Table 77. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 78. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 80. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 81. Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
Table 82. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 83. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 85. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 86. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
Table 87. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 88. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
Table 90. Aurisco Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 91. Aurisco Pharmaceutical Co., Ltd. Major Business
Table 92. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 93. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Aurisco Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 95. Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information, Head Office, and Major Competitors
Table 96. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 97. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 98. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments and Future Plans
Table 100. Chengdu Easton Biopharmaceuticals Co., Ltd. Company Information, Head Office, and Major Competitors
Table 101. Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
Table 102. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 103. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments and Future Plans
Table 105. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 106. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 107. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 108. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 110. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 111. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 112. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 113. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
Table 115. Yangtze River Pharmaceutical Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 116. Yangtze River Pharmaceutical Group Co., Ltd. Major Business
Table 117. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 118. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
Table 120. Zhejiang Nuode Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 121. Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
Table 122. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 123. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 125. Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 126. Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
Table 127. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 128. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 129. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 130. Chengdu Better Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 131. Chengdu Better Pharmaceutical Co., Ltd. Major Business
Table 132. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 133. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Chengdu Better Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 135. Shenyang Hongqi Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 136. Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
Table 137. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 138. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 140. Yichang Humanwell Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 141. Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
Table 142. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 143. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 145. Global Antiandrogen Drugs Revenue (USD Million) by Players (2021-2026)
Table 146. Global Antiandrogen Drugs Revenue Share by Players (2021-2026)
Table 147. Breakdown of Antiandrogen Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 148. Market Position of Players in Antiandrogen Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 149. Head Office of Key Antiandrogen Drugs Players
Table 150. Antiandrogen Drugs Market: Company Product Type Footprint
Table 151. Antiandrogen Drugs Market: Company Product Application Footprint
Table 152. Antiandrogen Drugs New Market Entrants and Barriers to Market Entry
Table 153. Antiandrogen Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 154. Global Antiandrogen Drugs Consumption Value (USD Million) by Structure (2021-2026)
Table 155. Global Antiandrogen Drugs Consumption Value Share by Structure (2021-2026)
Table 156. Global Antiandrogen Drugs Consumption Value Forecast by Structure (2027-2032)
Table 157. Global Antiandrogen Drugs Consumption Value by Application (2021-2026)
Table 158. Global Antiandrogen Drugs Consumption Value Forecast by Application (2027-2032)
Table 159. North America Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 160. North America Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 161. North America Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 162. North America Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 163. North America Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 164. North America Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 165. Europe Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 166. Europe Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 167. Europe Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 168. Europe Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 169. Europe Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 170. Europe Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 171. Asia-Pacific Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 172. Asia-Pacific Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 173. Asia-Pacific Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 174. Asia-Pacific Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 175. Asia-Pacific Antiandrogen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 176. Asia-Pacific Antiandrogen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 177. South America Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 178. South America Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 179. South America Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 180. South America Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 181. South America Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 182. South America Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 183. Middle East & Africa Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 184. Middle East & Africa Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 185. Middle East & Africa Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 186. Middle East & Africa Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 187. Middle East & Africa Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 188. Middle East & Africa Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 189. Global Key Players of Antiandrogen Drugs Upstream (Raw Materials)
Table 190. Global Antiandrogen Drugs Typical Customers
Table 1. Global Antiandrogen Drugs Consumption Value by Structure, (USD Million), 2021 & 2025 & 2032
Table 2. Global Antiandrogen Drugs Consumption Value by Shape, (USD Million), 2021 & 2025 & 2032
Table 3. Global Antiandrogen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Antiandrogen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Antiandrogen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 6. Astellas Pharma Inc. Company Information, Head Office, and Major Competitors
Table 7. Astellas Pharma Inc. Major Business
Table 8. Astellas Pharma Inc. Antiandrogen Drugs Product and Solutions
Table 9. Astellas Pharma Inc. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Astellas Pharma Inc. Recent Developments and Future Plans
Table 11. Johnson & Johnson Innovative Medicine Company Information, Head Office, and Major Competitors
Table 12. Johnson & Johnson Innovative Medicine Major Business
Table 13. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Product and Solutions
Table 14. Johnson & Johnson Innovative Medicine Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Johnson & Johnson Innovative Medicine Recent Developments and Future Plans
Table 16. Bayer AG Company Information, Head Office, and Major Competitors
Table 17. Bayer AG Major Business
Table 18. Bayer AG Antiandrogen Drugs Product and Solutions
Table 19. Bayer AG Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. ANI Pharmaceuticals, Inc. Company Information, Head Office, and Major Competitors
Table 21. ANI Pharmaceuticals, Inc. Major Business
Table 22. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Product and Solutions
Table 23. ANI Pharmaceuticals, Inc. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. ANI Pharmaceuticals, Inc. Recent Developments and Future Plans
Table 25. Sun Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 26. Sun Pharmaceutical Industries Ltd. Major Business
Table 27. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
Table 28. Sun Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Sun Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 30. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 31. Teva Pharmaceutical Industries Ltd. Major Business
Table 32. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Product and Solutions
Table 33. Teva Pharmaceutical Industries Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 35. Apotex Inc. Company Information, Head Office, and Major Competitors
Table 36. Apotex Inc. Major Business
Table 37. Apotex Inc. Antiandrogen Drugs Product and Solutions
Table 38. Apotex Inc. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. Apotex Inc. Recent Developments and Future Plans
Table 40. Intas Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 41. Intas Pharmaceuticals Ltd. Major Business
Table 42. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Product and Solutions
Table 43. Intas Pharmaceuticals Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Intas Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 45. Cipla Ltd. Company Information, Head Office, and Major Competitors
Table 46. Cipla Ltd. Major Business
Table 47. Cipla Ltd. Antiandrogen Drugs Product and Solutions
Table 48. Cipla Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Cipla Ltd. Recent Developments and Future Plans
Table 50. Zydus Lifesciences Ltd. Company Information, Head Office, and Major Competitors
Table 51. Zydus Lifesciences Ltd. Major Business
Table 52. Zydus Lifesciences Ltd. Antiandrogen Drugs Product and Solutions
Table 53. Zydus Lifesciences Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. Zydus Lifesciences Ltd. Recent Developments and Future Plans
Table 55. Sandoz Group AG Company Information, Head Office, and Major Competitors
Table 56. Sandoz Group AG Major Business
Table 57. Sandoz Group AG Antiandrogen Drugs Product and Solutions
Table 58. Sandoz Group AG Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Sandoz Group AG Recent Developments and Future Plans
Table 60. Pinnacle Life Science Pvt. Ltd. Company Information, Head Office, and Major Competitors
Table 61. Pinnacle Life Science Pvt. Ltd. Major Business
Table 62. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Product and Solutions
Table 63. Pinnacle Life Science Pvt. Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Pinnacle Life Science Pvt. Ltd. Recent Developments and Future Plans
Table 65. Orion Corporation Company Information, Head Office, and Major Competitors
Table 66. Orion Corporation Major Business
Table 67. Orion Corporation Antiandrogen Drugs Product and Solutions
Table 68. Orion Corporation Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. Orion Corporation Recent Developments and Future Plans
Table 70. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 71. Zhejiang Hisun Pharmaceutical Co., Ltd. Major Business
Table 72. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 73. Zhejiang Hisun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 75. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 76. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Major Business
Table 77. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 78. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Shanghai Fudan Forward Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 80. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 81. Shanghai Zhaohui Pharmaceutical Co., Ltd. Major Business
Table 82. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 83. Shanghai Zhaohui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 85. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 86. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Major Business
Table 87. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 88. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
Table 90. Aurisco Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 91. Aurisco Pharmaceutical Co., Ltd. Major Business
Table 92. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 93. Aurisco Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Aurisco Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 95. Qilu Pharmaceutical (Hainan) Co., Ltd. Company Information, Head Office, and Major Competitors
Table 96. Qilu Pharmaceutical (Hainan) Co., Ltd. Major Business
Table 97. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 98. Qilu Pharmaceutical (Hainan) Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. Qilu Pharmaceutical (Hainan) Co., Ltd. Recent Developments and Future Plans
Table 100. Chengdu Easton Biopharmaceuticals Co., Ltd. Company Information, Head Office, and Major Competitors
Table 101. Chengdu Easton Biopharmaceuticals Co., Ltd. Major Business
Table 102. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 103. Chengdu Easton Biopharmaceuticals Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Chengdu Easton Biopharmaceuticals Co., Ltd. Recent Developments and Future Plans
Table 105. Sichuan Kelun Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 106. Sichuan Kelun Pharmaceutical Co., Ltd. Major Business
Table 107. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 108. Sichuan Kelun Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Sichuan Kelun Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 110. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 111. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 112. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 113. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
Table 115. Yangtze River Pharmaceutical Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 116. Yangtze River Pharmaceutical Group Co., Ltd. Major Business
Table 117. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 118. Yangtze River Pharmaceutical Group Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. Yangtze River Pharmaceutical Group Co., Ltd. Recent Developments and Future Plans
Table 120. Zhejiang Nuode Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 121. Zhejiang Nuode Pharmaceutical Co., Ltd. Major Business
Table 122. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 123. Zhejiang Nuode Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 124. Zhejiang Nuode Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 125. Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 126. Jiangxi Kerui Pharmaceutical Co., Ltd. Major Business
Table 127. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 128. Jiangxi Kerui Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 129. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 130. Chengdu Better Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 131. Chengdu Better Pharmaceutical Co., Ltd. Major Business
Table 132. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 133. Chengdu Better Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. Chengdu Better Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 135. Shenyang Hongqi Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 136. Shenyang Hongqi Pharmaceutical Co., Ltd. Major Business
Table 137. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 138. Shenyang Hongqi Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Shenyang Hongqi Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 140. Yichang Humanwell Pharmaceutical Co., Ltd. Company Information, Head Office, and Major Competitors
Table 141. Yichang Humanwell Pharmaceutical Co., Ltd. Major Business
Table 142. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Product and Solutions
Table 143. Yichang Humanwell Pharmaceutical Co., Ltd. Antiandrogen Drugs Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 144. Yichang Humanwell Pharmaceutical Co., Ltd. Recent Developments and Future Plans
Table 145. Global Antiandrogen Drugs Revenue (USD Million) by Players (2021-2026)
Table 146. Global Antiandrogen Drugs Revenue Share by Players (2021-2026)
Table 147. Breakdown of Antiandrogen Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 148. Market Position of Players in Antiandrogen Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 149. Head Office of Key Antiandrogen Drugs Players
Table 150. Antiandrogen Drugs Market: Company Product Type Footprint
Table 151. Antiandrogen Drugs Market: Company Product Application Footprint
Table 152. Antiandrogen Drugs New Market Entrants and Barriers to Market Entry
Table 153. Antiandrogen Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 154. Global Antiandrogen Drugs Consumption Value (USD Million) by Structure (2021-2026)
Table 155. Global Antiandrogen Drugs Consumption Value Share by Structure (2021-2026)
Table 156. Global Antiandrogen Drugs Consumption Value Forecast by Structure (2027-2032)
Table 157. Global Antiandrogen Drugs Consumption Value by Application (2021-2026)
Table 158. Global Antiandrogen Drugs Consumption Value Forecast by Application (2027-2032)
Table 159. North America Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 160. North America Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 161. North America Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 162. North America Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 163. North America Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 164. North America Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 165. Europe Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 166. Europe Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 167. Europe Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 168. Europe Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 169. Europe Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 170. Europe Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 171. Asia-Pacific Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 172. Asia-Pacific Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 173. Asia-Pacific Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 174. Asia-Pacific Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 175. Asia-Pacific Antiandrogen Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 176. Asia-Pacific Antiandrogen Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 177. South America Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 178. South America Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 179. South America Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 180. South America Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 181. South America Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 182. South America Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 183. Middle East & Africa Antiandrogen Drugs Consumption Value by Structure (2021-2026) & (USD Million)
Table 184. Middle East & Africa Antiandrogen Drugs Consumption Value by Structure (2027-2032) & (USD Million)
Table 185. Middle East & Africa Antiandrogen Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 186. Middle East & Africa Antiandrogen Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 187. Middle East & Africa Antiandrogen Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 188. Middle East & Africa Antiandrogen Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 189. Global Key Players of Antiandrogen Drugs Upstream (Raw Materials)
Table 190. Global Antiandrogen Drugs Typical Customers
LIST OF FIGURES
Figure 1. Antiandrogen Drugs Picture
Figure 2. Global Antiandrogen Drugs Consumption Value by Structure, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Antiandrogen Drugs Consumption Value Market Share by Structure in 2025
Figure 4. Nonsteroidal Antiandrogens
Figure 5. Steroidal Antiandrogens
Figure 6. Global Antiandrogen Drugs Consumption Value by Shape, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Antiandrogen Drugs Consumption Value Market Share by Shape in 2025
Figure 8. Tablets
Figure 9. Capsules
Figure 10. Soft Capsules
Figure 11. Global Antiandrogen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Antiandrogen Drugs Consumption Value Market Share by Application in 2025
Figure 13. Non-Metastatic Castration-Resistant Prostate Cancer Picture
Figure 14. Metastatic Castration-Resistant Prostate Cancer Picture
Figure 15. Metastatic Castration-Sensitive Prostate Cancer Picture
Figure 16. High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer Picture
Figure 17. Global Antiandrogen Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 18. Global Antiandrogen Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 19. Global Market Antiandrogen Drugs Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 20. Global Antiandrogen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 21. Global Antiandrogen Drugs Consumption Value Market Share by Region in 2025
Figure 22. North America Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 27. Company Three Recent Developments and Future Plans
Figure 28. Global Antiandrogen Drugs Revenue Share by Players in 2025
Figure 29. Antiandrogen Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 30. Market Share of Antiandrogen Drugs by Player Revenue in 2025
Figure 31. Top 3 Antiandrogen Drugs Players Market Share in 2025
Figure 32. Top 6 Antiandrogen Drugs Players Market Share in 2025
Figure 33. Global Antiandrogen Drugs Consumption Value Share by Structure (2021-2026)
Figure 34. Global Antiandrogen Drugs Market Share Forecast by Structure (2027-2032)
Figure 35. Global Antiandrogen Drugs Consumption Value Share by Application (2021-2026)
Figure 36. Global Antiandrogen Drugs Market Share Forecast by Application (2027-2032)
Figure 37. North America Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 38. North America Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 39. North America Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 40. United States Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 41. Canada Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 42. Mexico Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 43. Europe Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 44. Europe Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 45. Europe Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 47. France Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 52. Asia-Pacific Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 53. Asia-Pacific Antiandrogen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 54. China Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. India Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. South America Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 61. South America Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 62. South America Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 66. Middle East & Africa Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 68. Turkey Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Saudi Arabia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. UAE Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Antiandrogen Drugs Market Drivers
Figure 72. Antiandrogen Drugs Market Restraints
Figure 73. Antiandrogen Drugs Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Antiandrogen Drugs Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Figure 1. Antiandrogen Drugs Picture
Figure 2. Global Antiandrogen Drugs Consumption Value by Structure, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Antiandrogen Drugs Consumption Value Market Share by Structure in 2025
Figure 4. Nonsteroidal Antiandrogens
Figure 5. Steroidal Antiandrogens
Figure 6. Global Antiandrogen Drugs Consumption Value by Shape, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Antiandrogen Drugs Consumption Value Market Share by Shape in 2025
Figure 8. Tablets
Figure 9. Capsules
Figure 10. Soft Capsules
Figure 11. Global Antiandrogen Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 12. Antiandrogen Drugs Consumption Value Market Share by Application in 2025
Figure 13. Non-Metastatic Castration-Resistant Prostate Cancer Picture
Figure 14. Metastatic Castration-Resistant Prostate Cancer Picture
Figure 15. Metastatic Castration-Sensitive Prostate Cancer Picture
Figure 16. High-Risk Biochemical Recurrent Non-Metastatic Castration-Sensitive Prostate Cancer Picture
Figure 17. Global Antiandrogen Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 18. Global Antiandrogen Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 19. Global Market Antiandrogen Drugs Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 20. Global Antiandrogen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 21. Global Antiandrogen Drugs Consumption Value Market Share by Region in 2025
Figure 22. North America Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 27. Company Three Recent Developments and Future Plans
Figure 28. Global Antiandrogen Drugs Revenue Share by Players in 2025
Figure 29. Antiandrogen Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 30. Market Share of Antiandrogen Drugs by Player Revenue in 2025
Figure 31. Top 3 Antiandrogen Drugs Players Market Share in 2025
Figure 32. Top 6 Antiandrogen Drugs Players Market Share in 2025
Figure 33. Global Antiandrogen Drugs Consumption Value Share by Structure (2021-2026)
Figure 34. Global Antiandrogen Drugs Market Share Forecast by Structure (2027-2032)
Figure 35. Global Antiandrogen Drugs Consumption Value Share by Application (2021-2026)
Figure 36. Global Antiandrogen Drugs Market Share Forecast by Application (2027-2032)
Figure 37. North America Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 38. North America Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 39. North America Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 40. United States Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 41. Canada Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 42. Mexico Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 43. Europe Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 44. Europe Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 45. Europe Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 46. Germany Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 47. France Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 48. United Kingdom Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 49. Russia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 50. Italy Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 51. Asia-Pacific Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 52. Asia-Pacific Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 53. Asia-Pacific Antiandrogen Drugs Consumption Value Market Share by Region (2021-2032)
Figure 54. China Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. Japan Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. South Korea Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. India Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 58. Southeast Asia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 59. Australia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 60. South America Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 61. South America Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 62. South America Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Antiandrogen Drugs Consumption Value Market Share by Structure (2021-2032)
Figure 66. Middle East & Africa Antiandrogen Drugs Consumption Value Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Antiandrogen Drugs Consumption Value Market Share by Country (2021-2032)
Figure 68. Turkey Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Saudi Arabia Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. UAE Antiandrogen Drugs Consumption Value (2021-2032) & (USD Million)
Figure 71. Antiandrogen Drugs Market Drivers
Figure 72. Antiandrogen Drugs Market Restraints
Figure 73. Antiandrogen Drugs Market Trends
Figure 74. Porters Five Forces Analysis
Figure 75. Antiandrogen Drugs Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
